ATE453380T1 - Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen - Google Patents

Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Info

Publication number
ATE453380T1
ATE453380T1 AT02743969T AT02743969T ATE453380T1 AT E453380 T1 ATE453380 T1 AT E453380T1 AT 02743969 T AT02743969 T AT 02743969T AT 02743969 T AT02743969 T AT 02743969T AT E453380 T1 ATE453380 T1 AT E453380T1
Authority
AT
Austria
Prior art keywords
administration
lipid vesicles
hydrophilic molecules
small hydrophilic
molecules packaged
Prior art date
Application number
AT02743969T
Other languages
English (en)
Inventor
Robert Friesen
Berend Poolman
Bernard Lucas Feringa
Jan Engberts
Original Assignee
Applied Nanosystems Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Nanosystems Bv filed Critical Applied Nanosystems Bv
Application granted granted Critical
Publication of ATE453380T1 publication Critical patent/ATE453380T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
AT02743969T 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen ATE453380T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202401A EP1269993A1 (de) 2001-06-21 2001-06-21 Verabreichung von in Lipidvesikeln verpackten kleinen hydrophilen Molekülen
PCT/NL2002/000412 WO2003000233A2 (en) 2001-06-21 2002-06-21 Delivery of small hydrophilic molecules packaged into lipid vesicles

Publications (1)

Publication Number Publication Date
ATE453380T1 true ATE453380T1 (de) 2010-01-15

Family

ID=8180516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02743969T ATE453380T1 (de) 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Country Status (7)

Country Link
US (1) US20030118636A1 (de)
EP (2) EP1269993A1 (de)
AT (1) ATE453380T1 (de)
CA (1) CA2451148A1 (de)
DE (1) DE60234921D1 (de)
DK (1) DK1397123T3 (de)
WO (1) WO2003000233A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135943A1 (de) 2001-07-30 2009-12-23 Meso Scale Technologies, LLC. Prüfelektrode mit festen Lipid- bzw. Proteinschichten, Herstellungsverfahren dafür und Verfahren zu deren Verwendung bei Lumineszenzprüfmessungen
AU2003225689B2 (en) * 2002-03-05 2009-03-26 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
PT1581236E (pt) * 2002-10-29 2013-12-24 Insmed Inc Libertação prolongada de anti-infecciosos
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7968115B2 (en) 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US7459147B2 (en) 2003-06-30 2008-12-02 L'oreal Cosmetic composition comprising at least one hydrophilic organopolysiloxane, at least one hydrocarbon oil and at least one short hydrocarbon ester
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
EP3067046B1 (de) * 2005-12-08 2020-03-25 Insmed Incorporated Antiinfektive zusammensetzungen auf lipidbasis zur behandlung von lungeninfekten
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
WO2009013115A2 (en) * 2007-07-20 2009-01-29 Basf Se Vesicles comprising a transmembrane transport trigger system
EP2127640A1 (de) 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Modifizierte azid-enthaltende Proteine
EP2446713B1 (de) 2009-06-24 2015-10-21 Koninklijke Philips N.V. Verfahren und einrichtung zum programmieren eines mikrocontrollers
WO2011097480A1 (en) * 2010-02-05 2011-08-11 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
SI2852391T1 (sl) 2012-05-21 2022-04-29 Insmed Incorporated Sistemi za obravnavo pljučnih infekcij
WO2014081300A1 (en) * 2012-11-22 2014-05-30 Tagworks Pharmaceuticals B.V. Channel protein activatable liposomes
CA2891487A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
KR102310921B1 (ko) 2013-03-14 2021-10-13 다이서나 파마수이티컬, 인크. 음이온성 약제를 제형화하는 방법
DK3466432T3 (da) 2014-05-15 2020-09-28 Insmed Inc Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5436170A (en) * 1987-07-27 1995-07-25 Commonwealth Scientific And Industrial Research Organization Receptor membranes
US5227470A (en) * 1988-08-26 1993-07-13 Canon Kabushiki Kaisha Method for forming proteoliposome and method for forming giant proteoliposome
JP2927942B2 (ja) * 1989-01-27 1999-07-28 オーストラリアン メンブレイン アンド バイオテクノロジィ リサーチ インスティチュート 受容体膜およびイオノホアのゲーテイング
US5874316A (en) * 1989-01-27 1999-02-23 Australian Membrane Biotechnology Research Institute Receptor membranes and ionophore gating
US5252348A (en) * 1990-10-19 1993-10-12 Univ. Of Florida Research Foundation, Inc. Artificial viral envelopes
US5753258A (en) * 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
EP1162271A3 (de) * 1994-11-18 2003-01-15 Stichting Nederlands Instituut Voor Zuivelonderzoek Verfahren zur Kontrolle der Genexpression in Milchsäurebakterien
WO1999003889A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
US6165732A (en) * 1997-10-14 2000-12-26 Washington University Method for identifying apoptosis modulating compounds
GB9721901D0 (en) * 1997-10-16 1997-12-17 Univ Manchester Particles

Also Published As

Publication number Publication date
DE60234921D1 (de) 2010-02-11
DK1397123T3 (da) 2010-05-03
CA2451148A1 (en) 2003-01-03
WO2003000233A3 (en) 2003-10-16
EP1397123B1 (de) 2009-12-30
US20030118636A1 (en) 2003-06-26
EP1269993A1 (de) 2003-01-02
EP1397123A2 (de) 2004-03-17
WO2003000233A2 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
ATE453380T1 (de) Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen
NO20001683L (no) Peptid/lipid-kompleksdannelse ved samlyofilisering
DE69823055D1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
DE69508598T2 (de) Mit polyethylenglycol modifizierte ceramidlipide und liposomen
ATE223232T1 (de) Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen
ID27788A (id) Peptida-peptida antigen tumor yang diperoleh dari siklofilin b
CY1120831T1 (el) Μεθοδοι μειωσης της συσσωματωσης toy il-1ra
CY2604B2 (en) Pharmaceutical preparations for drugs of low solubility
ATE273320T1 (de) Fusogene liposomen
NO993257D0 (no) N-acylfosfatidyletanolaminformidlet liposomal legemiddelavlevering
TR200400295T2 (tr) Kimyasal olarak modifiye edilmiş ensülin'in akçiğer yoluyla verilmesi
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
NO990276L (no) Ultralydavbildning av lever
CY1105953T1 (el) Συνθεσεις για απελευθερωση συνδυασμων φαρμακων
ATE322255T1 (de) Polyamid-oligomere
ATE354652T1 (de) Vektorkonstrukte
ATE252888T1 (de) Lipid haltige zusammenstellungen und deren verwendungen
ATE373466T1 (de) Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
BR0207654A (pt) Composição que compreende um creme ou loção base
DE60137835D1 (de) Modifizierte zytokine für krebs therapie
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
ATE345778T1 (de) (ester)-lysolecithine in liposomen
CY1106306T1 (el) Παραγωγα 5-ιμινο-13-δεοξυ ανθρακυκλινης, οι χρησεις τους και διepγασιες παρασκευης αυτων
TR199701225A2 (xx) Gen terapisi için katyonik lipidler.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties